참고문헌
- Berger J, Hinglais N. Intercapillary deposits of IgA-G. J Urol Nephrol 1968;74;694-5
- DAmico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987;64:709-27
- DAmico G. Natural history of IgA nephropathy and factors predictive of disease outcome. Semin Nephrol, 2004;24:179-96 https://doi.org/10.1016/j.semnephrol.2004.01.001
- Coppo R, DAmico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005;18:503-127
- Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Jahnukainen T, Koskimies O, Merenmies J, et al. Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study. Pediatr Nephrol 2006;21:1266-73 https://doi.org/10.1007/s00467-006-0163-x
- Kusumoto Y. Takebayashi S. Taguchi T. Harada T. Naito S. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. Clin Nephrol 1987;28:118-24
- Wyatt RJ, Kritchevsky SB, Woodford SY, Miller PM, Roy S 3rd, Holland NH, et al. IgA nephropathy: long-term prognosis for pediatric patients. J Pediatr 1995;127:913-9 https://doi.org/10.1016/S0022-3476(95)70027-7
- Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-63
- Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration to estimate glomerular filtration rate in infancy, childhood, adolescence. Pediatr Clin North Am 1987:34;571-90 https://doi.org/10.1016/S0031-3955(16)36251-4
- Lee JK. Standard blood pressure of child and adolescent in 2005. Program and Abstract, 56th Annual Spring Meeting of The Korean Pediatric Society; 2006 Apr 28-29; Yong- Pyung, Seoul : The Korean Pediatric Society 2006:63-90
- Haas M. Histologic subclass of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997;29: 829-42 https://doi.org/10.1016/S0272-6386(97)90456-X
- Yosikawa N. Immunoglobulin A nephropathy. In : Qvener ED, Harmon WE, Niadet P. Pediatric nephrology. 5th ed. Philadelphia : LW & Wilkins Co 2004:615-28
- Utsunomiya Y, Kado T, Koda T, Okada S, Hayashi A. Fukuwaza A, et al. Features of IgA nephropathy in preschool children. Clin Nephrol 2000;54:443-8
- Yoshikawa N, Tanaka R, Iijima K. Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 2001;16:446-57 https://doi.org/10.1007/s004670100582
- Park YH, Choi JY, Chung HS, Koo JW, Kim SY, Namgoong MK, et al. Hematuria and proteinuria in a mass school screening test. Pediatr Nephrol 2005;20:1126-30 https://doi.org/10.1007/s00467-005-1915-8
- Nozawa R, Suzuki J, Takahashi A, Isome M, Kawasaki Y, Suzuki S, et al. Clinicopathological features and the prognosis of IgA nephropathy in Japanese children on longterm observation. Clin Nephrol 2005:64;171-9 https://doi.org/10.5414/CNP64171
- Ariceta G, Gallego N, Lopez.Fernandez Y, Lopez Fernandez Y, Vallo A, Quintela MJ, el al. Long.term prognosis of childhood IgA nephropathy in adult life. Med Clin(Brac) 2001;116:361-4 https://doi.org/10.1016/S0025-7753(01)71831-3
- Yosikawa N, Iijima K, Ito H. IgA nephropathy in children. Nephron 1999;83:1-12 https://doi.org/10.1159/000045467
- Lee JS, Kwon JH, Choi EN, Park JM, Jeung HJ. A clinicopathologic study on the prognosis of IgA nephropathy in children. J Korean Soc Pediatr Nephrol 2003:7;23-9
- Andreoli SP, Yum MN, Bergstein JM. IgA nephropathy in children : significance of glomerular base membrane deposition of IgA. Am J Nephrol 1986;6:28-33 https://doi.org/10.1159/000167049
- Delos Santos NM, Ault BH, Gharavi AG, Kritchevsky SB, Quasney MW, Jackson EC, et al. Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol 2002;17:496-502 https://doi.org/10.1007/s00467-002-0916-0
- Hogg RJ, Silva FG, Wyatt RJ, Reisch JS, Argyle JE, Savino DA. Prognostic indicators in children with IgA nephropathy: Report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 1994;8:15-20 https://doi.org/10.1007/BF00868251
- Delos Santos NM, Wyatt RJ. Pediatric IgA nephropathy: clinical aspects and therapeutic approaches. Semin Nephrol 2004:24;269-86 https://doi.org/10.1016/j.semnephrol.2004.01.007
- Yoshikawa N, Ito H, Yoshihara S, Nakagara C. Yoshiya K, Hasegawa O, et al. Clinical course of Immunoglobulin A nephropathy in children. J Pediatr 1987;110:555-60 https://doi.org/10.1016/S0022-3476(87)80547-4
- Holt RCL, Connell JE, Addison GM. Reference data for pediatric nephrology. In : Webb NJA, Postlethwaite RJ. Clinical pediatric nephrology. 3rd edition. Oxford : Oxford University Press 2003:493-509
- Yoshikawa N, Ito H, Nakamura H. Prognostic indicators in childhood IgA nephropathy. Nephron 1992;60:60-7 https://doi.org/10.1159/000186706
- Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, et al. Histologic difference in newly onset IgA nephropathy between children and adults. Nephrol Dial Transplant 2006:1-9
- Shigematsu H, Ito N, Ishigame H, Ehara T, Kato M, Washizawa K, et al. Age-related character of glomerular lesions in IgA nephritis(2). Histopathological peculiarity in childhood onset. Nippon Jinxo Gakkai Shi 1992;34:33-9
- DAmico G. Imbasciati E, Barbiano Di Belgioioso G. Bertoli S. Bertoli S, Fogazzi G, et al. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine(Baltimore) 1985;64:49-60 https://doi.org/10.1097/00005792-198501000-00004
- The Southwest Pediatric Nephrology Study Group. A multicenter study of IgA nephropathy in children. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 1982;22:643-52 https://doi.org/10.1038/ki.1982.224
- Levi M, Gonzalez-Buschard G, Broyer M, Dommergues J, Foulard M, Sorez J, et al. Bergers disease in children. Natural history and outcome. Medicine(Baltimore) 1985;64: 157-80
- Nolin L, Courteau M. Management of IgA nephropathy: evidence-based recommendation. Kidney Int 1999;70:s62-9
- Floege J. Evidence-based recommendation for immunosuppression in IgA nephropathy: handle with caution. Nephrol Dial Transplant 2003;18:241-5 https://doi.org/10.1093/ndt/18.2.241
- Maschio G, Gagnoli L, Claroni F, Fusaroli M, Ruqiu C, Sanna G, et al. ACE inhibition reduces proteinuira in normotensive patients with IgA nephropathy: A multicenter, randomizd, placebo-controlled study. Nephol Dial Transplant 1994;9:265-9
- Hebert LE, Wilmer WA, Falkenhain ME, Ladson-Wofford SE. Nahman NS Jr, Robin BH. Renoprotection: one or many therapies? Kidney Int 2001;59:1211-23 https://doi.org/10.1046/j.1523-1755.2001.0590041211.x
- Bhattacharjee R, Filler G. Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy. Pediatr Nephrol 2002;17:302-4 https://doi.org/10.1007/s00467-002-0829-y
- Hogg RJ, Wyatt RJ. Scientific Planning Committee of the North American IgA Nephropathy Study. A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy. BMC Nephrol 2004;5:3 https://doi.org/10.1186/1471-2369-5-3
- Coppo R. Chiesa M, Peruzzi L, Amore A. Treatment of IgA nephropathy with anigiotensin converting enzyme inhibiter: design of a prospective randomized multicenter trial. J Nephrol 2001:14;447-52